NCT05996913

Brief Summary

This trial will explore the feasibility and acceptability of an intervention for Somatic flashbacks in Post-Traumatic Stress Disorder (PTSD). Imagery Rescripting (ImRs) will form a central part of the intervention. The primary objective of this trial is to explore the acceptability and feasibility of delivering an intervention for the management of somatic flashbacks to a population of adults experiencing post-traumatic stress disorder. The secondary objectives of this trial will be to examine if the intervention leads to any differences in participants experience of somatic flashbacks and their global symptoms of PTSD.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
15

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 25, 2023

Completed
24 days until next milestone

First Posted

Study publicly available on registry

August 18, 2023

Completed
3 months until next milestone

Study Start

First participant enrolled

November 1, 2023

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2024

Completed
Last Updated

January 12, 2024

Status Verified

January 1, 2024

Enrollment Period

7 months

First QC Date

July 25, 2023

Last Update Submit

January 11, 2024

Conditions

Outcome Measures

Primary Outcomes (4)

  • Treatment Acceptability/Adherence Scale score

    The Treatment Acceptability/Adherence Scale measures a participants experience of an intervention. The questionnaire is made of up 10 items and each item is measured on a scale from 1 (disagree strongly) to 7 (Agree strongly).

    Through study completion, an average of 8 weeks

  • What percentage of participants using the service are eligible agreed to take part?

    The percentage of participants who access the service who meet the eligibility criteria for the intervention

    1 year

  • What percentage of participants who are eligible to take part, accept the intervention offer?

    The percentage of participants who meet the eligibility criteria for the intervention and agree to take part in the trial.

    1 year

  • What percentage of participants completed treatment?

    The percentage of participants who agree to take part in the trial who go on to complete the intervention.

    1 year

Secondary Outcomes (5)

  • Changes in the frequency of somatic flashbacks

    Through study completion, an average of 8 weeks

  • Changes in the intensity of somatic flashbacks

    Through study completion, an average of 8 weeks

  • Changes in the distress associated with somatic flashbacks

    Through study completion, an average of 8 weeks

  • Changes in participants sense of ability to cope with the somatic flashbacks

    Through study completion, an average of 8 weeks

  • Changes in global symptoms of PTSD

    Through study completion, an average of 8 weeks

Study Arms (1)

Intervention

EXPERIMENTAL

Imagery rescripting intervention for somatic flashback

Other: Imagery rescripting

Interventions

The current project aims to explore the feasibility of intervention featuring imagery rescripting (ImRs) and grounding in the management of somatic flashbacks amongst this population. ImRs was developed as a method to help activate a traumatic memory, bring corrective information into the memory, create a more favourable outcome to the memory and to support the participant to discover and express inhibited trauma-related emotional responses (Arntz \& Weertman, 1999).

Intervention

Eligibility Criteria

Age16 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Aged 18 and above
  • DSM-5 diagnosis of PTSD or Complex PTSD
  • Participants who are currently experiencing somatic flashbacks
  • Willing and able to provide written informed consent to treatment

You may not qualify if:

  • Currently receiving another trauma-focussed intervention
  • Active suicidal intent or recent (past 8 weeks) suicide attempt
  • Currently abusing substances
  • Participants whose participation in the study is not considered in their best interest by the clinical team at Traumatic Stress Clinic and Woodfield Trauma Service
  • Participants who do not consent to the intervention sessions being recorded
  • Participants who do not consent to their assessment information being made available to the trainee clinical psychologist carrying out the intervention

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Traumatic Stress clinic

London, United Kingdom

RECRUITING

Woodfield Trauma service

London, United Kingdom

RECRUITING

MeSH Terms

Conditions

Stress Disorders, Post-Traumatic

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental Disorders

Study Officials

  • Livia Ottisova, Doctorate

    Camden and Islington NHS

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 25, 2023

First Posted

August 18, 2023

Study Start

November 1, 2023

Primary Completion

June 1, 2024

Study Completion

June 1, 2024

Last Updated

January 12, 2024

Record last verified: 2024-01

Data Sharing

IPD Sharing
Will not share

Locations